Search

Neglected tropical diseases (NTDs) predominantly affect vulnerable and marginalized populations in tropical and subtropical areas and globally affect more than one billion people. In Guinea, the burden of NTDs is estimated to be >7.5 disability-adjusted life years per million inhabitants. Currently the Guinea NTDs master plan (2017–2020) has identified eight diseases as public health problems: onchocerciasis, lymphatic filariasis, trachoma, schistosomiasis and soil-transmitted helminthiasis, leprosy, human African trypanosomiasis and Buruli ulcer. In this review we discuss the past and the current case burden of the priority NTDs in Guinea, highlight the major milestones and discuss current and future areas of focus for achieving the 2030 target outlined by the World Health Organization.

In this case report, we describe a clinical presentation and therapeutic history of a unique case diagnosed with Lassa fever and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a 23-year-old man from Yomou prefecture in southeast Guinea identified with suspected Ebola Virus Disease (EVD) in the midst of an ongoing outbreak of that disease in the same region. On May 3, 2021, he was admitted to the Nzérékoré Epidemic disease treatment center where his clinical condition deteriorated significantly. Laboratory testing performed on the same day reveals a negative EVD polymerase chain reaction (PCR). Three days later, the patient was tested positive for SARS-CoV-2 and Lassa fever by reverse transcriptase PCR (RT-PCR) assays. Laboratory examination also indicated severe hematological and biochemical deteriorations in the patient. This case substantiates the need for systematic differential diagnosis during epidemic-prone disease outbreaks to better manage severely unwell patients.

BackgroundDespite tremendous progress on Ebola Virus Disease (EVD), challenges remain in the implementation of holistic strategies to quickly stop outbreaks. We investigated the effectiveness of a community-based confinement strategy to limit the spread of EVD during the tenth documented EVD outbreak in the Democratic Republic of the Congo (DRC), 2018 - 2020.MethodsWe did a community-based, open-label, two-group, unrandomized controlled intervention. Eligible participants were EVD contacts registered by epidemiological surveillance teams from November 2019 to May 2020 in the two last hotspots (Beni and Mabalako Health Zones). Intervention group participants were confined in specific community sites of their preference for the duration of their follow-up. Control group participants underwent CT without confinement and were allowed to continue their daily activities. The primary outcome was the number of confirmed secondary cases in the two groups. Secondary outcomes included delay between symptom onset and isolation, case fatality rate, survival rate, and vaccination rate. Data were analyzed using various quantitative methods.FindingsA total of 27,324 EVD contacts were included in the study. 585 contacts were confined and followed up (‘the intervention group’), and 26,739 were followed up without confinement. The intervention group generated 32 confirmed cases (5.5%) in the first generation, while the control group generated just 87 (0.3%). However, the 32 confirmed cases from the intervention contacts did not generate any onward transmission (R=0.00), whereas the 87 confirmed cases from the non-intervention group generated 99 secondary cases (R = 1.14). Results for the secondary outcomes showed significant difference between the two groups. The delay between symptom onset and case isolation was shorter (1.3 vs 4.8 days; pInterpretationThe community-based confinement strategy used in DRC is effective for the rapid cessation of EVD transmission, highlighting the importance of rapidly implemented, innovative and community-oriented control strategies.